对具有里程碑意义的心脏病药物试验的质疑：替卡格雷PLATO研究。 - Suppr

Suppr

超能文献

Doubts over landmark heart drug trial: ticagrelor PLATO study.

作者信息

Doshi Peter

机构信息

The BMJ.

出版信息

BMJ. 2024 Dec 11;387:q2550. doi: 10.1136/bmj.q2550.

DOI:10.1136/bmj.q2550

PMID:39662999

Abstract

摘要

相似文献

Doubts over landmark heart drug trial: ticagrelor PLATO study.对具有里程碑意义的心脏病药物试验的质疑：替卡格雷PLATO研究。

BMJ. 2024 Dec 11;387:q2550. doi: 10.1136/bmj.q2550.

Inferiority of ticagrelor in the PHILO trial: Play of chance in East Asians or nightmare confirmation of PLATO-USA?替格瑞洛在PHILO试验中的劣势：是东亚人群中的偶然因素，还是对PLATO-美国研究结果的噩梦般证实？

Int J Cardiol. 2016 Jul 15;215:372-6. doi: 10.1016/j.ijcard.2016.04.125. Epub 2016 Apr 19.

Verifying Death Reports in the Platelet Inhibition and Patient Outcomes (PLATO) Trial.验证血小板抑制和患者结局（PLATO）试验中的死亡报告。

Am J Ther. 2020 Nov/Dec;27(6):e563-e572. doi: 10.1097/MJT.0000000000001286.

Exploring the ticagrelor-statin interplay in the PLATO trial.在PLATO试验中探索替格瑞洛与他汀类药物的相互作用。

Cardiology. 2013;124(2):105-7. doi: 10.1159/000346151. Epub 2013 Feb 7.

Misreported Cancer Deaths in PLATO Trial.PLATO试验中癌症死亡报告错误

J Clin Med. 2021 Jul 16;10(14):3140. doi: 10.3390/jcm10143140.

The FDA outlook of events reporting after ticagrelor or clopidogrel in the PLATO Trial: impact of sponsor censoring dates, drug discontinuation, and withdrawal of consent.PLATO试验中替卡格雷或氯吡格雷用药后不良事件报告的FDA展望：申办方审查日期、药物停用及撤回同意书的影响

Cardiology. 2011;120(3):169-71. doi: 10.1159/000335476. Epub 2012 Jan 5.

Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO study.从美国视角对替格瑞洛治疗的经济学分析：来自 PLATO 研究的结果。

J Am Coll Cardiol. 2015 Feb 10;65(5):465-76. doi: 10.1016/j.jacc.2014.11.034.

[Subgroup analysis results of platelet inhibition trial in acute coronary syndrome patients (PLATO) who underwent intervention or medical treatment].

Turk Kardiyol Dern Ars. 2013 Apr;41 Suppl 1:17-22.

Impact of the reporting source on Platelet Inhibition and Treatment Outcomes (PLATO) trial deaths.报告来源对血小板抑制和治疗结果（PLATO）试验死亡情况的影响。

Discoveries (Craiova). 2023 Sep 25;11(3):e174. doi: 10.15190/d.2023.13. eCollection 2023 Jul-Sep.

Lifetime cost-effectiveness analysis of ticagrelor in patients with acute coronary syndromes based on the PLATO trial: a Singapore healthcare perspective.基于 PLATO 试验的急性冠状动脉综合征患者替格瑞洛的终生成本效益分析：新加坡医疗保健视角。

Singapore Med J. 2013 Mar;54(3):169-75. doi: 10.11622/smedj.2013045.

引用本文的文献

Pain in the body, harm to the heart: advances in research on the impact of chronic pain on cardiovascular diseases.身体疼痛，心脏受损：慢性疼痛对心血管疾病影响的研究进展

Front Cardiovasc Med. 2025 Aug 6;12:1629145. doi: 10.3389/fcvm.2025.1629145. eCollection 2025.

Impact of Central Event Adjudication on the PLATO Trial Results.中心事件裁决对PLATO试验结果的影响。

Rev Cardiovasc Med. 2025 Apr 27;26(4):36733. doi: 10.31083/RCM36733. eCollection 2025 Apr.

Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes trial (TC4): a Bayesian pragmatic cluster randomized controlled trial.替格瑞洛与氯吡格雷在急性冠脉综合征中的比较试验（TC4）：一项贝叶斯实用型整群随机对照试验

CMAJ. 2025 Mar 30;197(12):E309-E318. doi: 10.1503/cmaj.241862.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验